Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan.

[1]  Y. Chao,et al.  Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Hamada,et al.  Plasma lipids and lipoproteins in Japanese male patients with coronary artery disease and in their relatives. , 1982, Atherosclerosis.

[3]  B. Suarez,et al.  Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. , 1979, The Journal of laboratory and clinical medicine.

[4]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[5]  M. Kashyap,et al.  A rapid and simple method for measurement of total protein in very low density lipoproteins by the Lowry assay. , 1980, Journal of lipid research.

[6]  W. Hazzard,et al.  Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3. , 1979, Clinical chemistry.

[7]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[8]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[9]  R. Levy,et al.  Type III hyperlipoproteinemia: an analysis of two contemporary definitions. , 1975, Annals of internal medicine.

[10]  R J Havel,et al.  Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. , 1982, Journal of lipid research.

[11]  W. Hazzard,et al.  High-density lipoproteins in myocardial infarction survivors. , 1978, Metabolism: clinical and experimental.

[12]  A. Motulsky,et al.  Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. , 1973, The Journal of clinical investigation.

[13]  G. Cazzolato,et al.  Relationship between apolipoproteins and chemical components of lipoproteins in survivors of myocardial infarction. , 1980, Atherosclerosis.

[14]  W. Kannel,et al.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. , 2020, Annals of internal medicine.

[15]  O. Vesterberg,et al.  Staining of proteins after isoelectric focusing in gels by new procedures. , 1977, Biochimica et biophysica acta.

[16]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[17]  G. Utermann,et al.  Polymorphism of apolipoprotein E , 1979, Clinical genetics.

[18]  Y. Marcel,et al.  Increased Frequency of Apo E-ND phenotype and hyperapobeta-lipoproteinemia in normolipidemic subjects with xanthelasmas of the eyelids. , 1982, Annals of internal medicine.

[19]  G. Utermann,et al.  Polymorphism of apolipoprotein E , 1978, Clinical genetics.

[20]  B. Lewis,et al.  Plasma Lipids and Lipoproteins , 1970 .

[21]  垂井 清一郎,et al.  急性心筋梗塞患者におけるリポ蛋白組成および各種 risk factor の検討と冠動脈造影所見について , 1980 .

[22]  D. Porte,et al.  Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (type 3 hyperlipoproteinemia). , 1972, Metabolism: clinical and experimental.

[23]  G. Utermann,et al.  Polymorphism of apolipoprotein E , 1979, Clinical genetics.